(Q31120604)

29 June 2017

1 reference

title

The effects of antipsychotic treatment on cerebral structure and function in schizophrenia (English)

1 reference

29 June 2017

0 references

Antonio Vita

1

1 reference

PubMed ID

17671875

29 June 2017

Luca De Peri

series ordinal

2

1 reference

29 June 2017

1 August 2007

1 reference

International Review of Psychiatry

29 June 2017

1 reference

29 June 2017

19

1 reference

29 June 2017

4

1 reference

29 June 2017

429-436

1 reference

Effect of chronic olanzapine treatment on nerve growth factor and brain-derived neurotrophic factor in the rat brain

29 June 2017

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Striatal metabolic rate and clinical response to neuroleptics in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Striatal enlargement in rats chronically treated with neuroleptic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

The effects of neuroleptic medications on basal ganglia blood flow in schizophreniform disorders: a comparison between the neuroleptic-naïve and medicated states

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Positron emission tomography in schizophrenic patients with and without neuroleptic medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Cerebral cortical gray expansion associated with two second-generation antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

A morphometric MRI study of the hippocampus in first-episode, neuroleptic-naïve schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Functional effects of antipsychotic drugs: comparing clozapine with haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Gray matter abnormalities associated with duration of untreated psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Antipsychotic drug effects on brain morphology in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Quetiapine reverses the suppression of hippocampal neurogenesis caused by repeated restraint stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naïve schizophrenic patients: correlations with symptom change

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

NMDA receptor hypofunction model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Effect of clozapine on caudate nucleus volume in relation to symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

A review of MRI findings in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Effects of olanzapine on cerebellar functional connectivity in schizophrenia measured by fMRI during a simple motor task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Volumetric MRI measurement of caudate nuclei in antipsychotic-naive patients suffering from a first episode of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Meta-analysis of regional brain volumes in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

PET and MRI of the thalamus in never-medicated patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701486332

10.1080/09540260701486332

21 January 2018

Identifiers

DOI

1 reference

release_lqtejzaixzbwfjanvhppc7xy5m

29 June 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lqtejzaixzbwfjanvhppc7xy5m

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

17671875

1 reference

PubMed ID

17671875